E-viri
PDF
Recenzirano
Odprti dostop
-
Bunin, Yu. A.
Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii, 01/2010, Letnik: 6, Številka: 6Journal Article
Highlights of primary prevention of death in patients with ventricular arrhythmias (VA) are discussed. Overview of all main clinical trials exploring various anti-arrhythmic drugs in prevention of death in patients with VA is presented. It is emphasized that in patients with organic heart disease and VA only beta-blockers and amiodarone are able to reduce mortality, while other drugs have no effect on mortality, or they even increase mortality mainly due to arrhythmogenic effect. Recent clinical studies of the cardioverter-defibrillators efficacy in these patients are presented. It is shown that the use of cardioverter defibrillators compared with pharmacotherapy is more effective in prevention of fatal outcomes.
